Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 7, 2007, Pages 1477-1485

  Hayashi, T ^a   Nishioka, J ^a   Nakagawa, N ^a   Kamada, H ^a   Gabazza, E C ^a   Kobayashi, T ^b   Hattori, A ^b   Suzuki, Koji ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Hepatocyte growth factor; Hepatocyte growth factor activator; Homology modeling; Liver regeneration; Protein C inhibitor

Indexed keywords

ARGININE; ENZYME INHIBITOR; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 3; RECOMBINANT PROTEIN; SCATTER FACTOR; THROMBIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; COMPETITIVE INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RESIDUE ANALYSIS; TISSUE REGENERATION; TISSUE REPAIR;

ADULT; BASE SEQUENCE; DNA, COMPLEMENTARY; HEPATOCYTE GROWTH FACTOR; HUMANS; MACROMOLECULAR SUBSTANCES; MIDDLE AGED; MODELS, MOLECULAR; PROTEIN C; PROTEIN C INHIBITOR; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; THROMBIN; THROMBOMODULIN;

EID: 34250749673     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02594.x     Document Type: Article

References (31)

1. Colvin RB. Wound healing processes in hemostasis and thrombosis. In: Gimbrone MA, eds. Vascular Endothelium in Hemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1986: 220-41.
2. Kan M, Zhang G, Zarnegar R, Michalopoulos G, Myoken Y, McKeehan WL, Stevens JI. Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem Biophys Res Commun 1991; 17: 331-7.
3. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, Nakamura T, Ogihara T. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 1995; 215: 483-8.
4. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T, Kitamura N. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 1992; 267: 20114-9.
5. Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y, Kitamura M. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995; 229: 257-61.
6. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 1993; 268: 10024-8.
7. Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y, Kitamura N. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 1993; 268: 22927-32.
8. Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, Kagaya T, Qin L, Takata H, Miyazawa K, Kitamura N. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 1997; 272: 6370-6.
9. Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K, Kitamura N. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 1997; 272: 27558-64.
10. Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Kitamura N, Miyazawa K, Koono M. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 2000; 275: 40453-62.
11. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-8.
12. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 1984; 95: 187-95.
13. Suzuki K. Protein C inhibitor (PAI-3): Structure and multi-function. Fibrinol Proteol 2000; 14: 133-45.
14. Nishioka J, Ning M, Hayashi T, Suzuki K. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles. J Biol Chem 1998; 273: 11281-7.
15. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-101.
16. Rezaie AR, Cooper ST, Church FC, Esmon CT. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995; 270: 25336-9.
17. Suzuki K, Stenflo J, Dahlback B, Teodorsson B. In activation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-20.
18. Miletich JP, Broze GJ Jr, Majerus PW. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem 1980; 105: 304-10.
19. Suzuki K, Hayashi T, Nishioka J, Zushi M, Honda K, Yamamoto S, Hashimoto S. A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 1989; 264: 4872-6.
20. Suzuki K, Kusumoto H, Nishioka J, Komiyama Y. Bovine plasma protein C inhibitor with structural and functional homologous properties to human plasma protein C inhibitor. J Biochem (Tokyo) 1990; 107: 381-8.
21. Wakita T, Hayashi T, Tamaru H, Nishioka J, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Int J Cancer 2004; 108: 516-23.
22. Nakase T, Wada H, Minamikawa K, Wakita Y, Shimura M, Hiyoyama K, Tamaki S, Shirakawa S, Deguchi K, Nishioka J, Hayashi T, Suzuki K. Increased activated protein C-protein C inhibitor complex level in patients positive for lupus anticoagulant. Blood Coagul Fibrinol 1994; 5: 173-7.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
24. Ye S, Cech AL, Belmares R, Bergstrom RC, Tong Y, Corey DR, Kanost MR, Goldsmith EJ. The structure of a Michaelis serpin-protease complex. Nature Struct Biol 2001; 8: 979-83.
25. Molecular Operating Environment, version 2004.03; Montreal, Canada: Chemical Computing Group Inc., 2004.
26. Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon CT, Bode W. The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J 1996; 15: 6822-31.
27. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner PA. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 1984; 106: 765-84.
28. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzuki K. Protein S Tokushima: Abnormal molecule with substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 1994; 83: 683-90.
29. Asanuma K, Yoshikawa T, Hayashi T, Akita N, Nakagawa N, Hamada Y, Nishioka J, Kamada H, Gabazza EC, Ido M, Uchida A, Suzuki K. Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity. Int J Cancer 2007, in press.
30. Shirk RA, Elisen MG, Meijers JC, Church FC. Role of the H helix in heparin binding to protein C inhibitor. J Biol Chem 1994; 269: 28690-5.
31. Glasscock LN, Gerlitz B, Cooper ST, Grinnell BW, Church FC. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin. Biochim Biophys Acta 2003; 1649: 106-17.